Lilly to Acquire AurKa Pharma

Acquisition Expands Lilly Oncology Pipeline with Early-Phase Asset Being Studied in Multiple Tumor Types INDIANAPOLIS, May 14, 2018 -- (Healthcare Sales & Marketing Network) -- Eli Lilly and Company (NYSE: LLY) today announced an agreement to acquire A... Biopharmaceuticals, Oncology, Mergers & Acquisitions Eli Lilly, AurKa Pharma, Aurora kinase A inhibitor
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news